Xenon Pharmaceuticals Inc (XENE)
Cash & Short-Term Investments
$930.69M
Quarterly · Period ending: · USD
XENE Cash & Short-Term Investments
Latest reported$930.69Mperiod ending
Latest reported$930.69Mperiod ending
XENE Quarterly Cash & Short-Term Investments ($60.16M → $930.69M)
Quarterly Cash & Short-Term Investments
High-resolution chart · PNG
XENE cash & short-term investments history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cash & Short-Term Investments (USD) |
|---|---|
| 930,686,000 | |
| 1,094,747,000 | |
| 548,886,000 | |
| 462,268,000 | |
| 487,545,000 | |
| 549,629,000 | |
| 626,905,000 | |
| 654,015,000 | |
| 721,535,000 | |
| 699,602,000 | |
| 638,082,000 | |
| 526,674,000 | |
| 539,600,000 | |
| 527,043,000 | |
| 592,087,000 | |
| 638,185,000 | |
| 788,238,000 | |
| 537,940,000 | |
| 551,774,000 | |
| 249,625,000 | |
| 260,523,000 | |
| 274,703,000 | |
| 176,997,000 | |
| 190,927,000 | |
| 202,754,000 | |
| 229,671,000 | |
| 141,358,000 | |
| 94,603,000 | |
| 101,801,000 | |
| 110,429,000 | |
| 119,306,000 | |
| 127,128,000 | |
| 63,270,000 | |
| 35,078,000 | |
| 43,667,000 | |
| 43,772,000 | |
| 51,696,000 | |
| 58,027,000 | |
| 64,146,000 | |
| 69,491,000 | |
| 50,738,000 | |
| 56,064,000 | |
| 58,651,000 | |
| 65,469,000 | |
| 73,700,000 | |
| 75,381,000 | |
| 84,041,000 | |
| 47,936,000 | |
| 44,710,000 | |
| 49,276,000 | |
| 49,276,000 | |
| 49,812,000 | |
| 49,812,000 | |
| 60,162,000 | |
| 60,162,000 |